Protein Variants | Comment | Organism |
---|---|---|
I54G | the ability of the mutant enzyme to cleave the pseudosymmetrical peptide substrate Ac-Tyr-Arg-Ala-Arg-Val-Phe-4-nitrophenylalanyl-Val-Arg-Ala-Ala-Lys is more than an order of magnitude lower than that of the wild-type enzyme | equine infectious anemia virus |
I54G/Y48H | specificity constant is only 3fold lower than that measured for the single mutant I54G enzyme, towards the long, pseudosymmetrical peptide substrate Ac-Tyr-Arg-Ala-Arg-Val-Phe-4-nitrophenylalanyl-Val-Arg-Ala-Ala-Lys. The potency of the shorter HBY-793 inhibitor is reduced by 60fold compared to the Ki values measured against the wild-type or the I54G mutant enzyme | equine infectious anemia virus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
HBY-793 | - |
equine infectious anemia virus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | equine infectious anemia virus | the enzyme is essential for processing gag and gal-pol polyproteins in order to generate new infectious viral particles | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
equine infectious anemia virus | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | the enzyme is essential for processing gag and gal-pol polyproteins in order to generate new infectious viral particles | equine infectious anemia virus | ? | - |
? |